Skip to main content
. 2019 Sep 12;11(9):2203. doi: 10.3390/nu11092203
AR androgen receptor
BPH benign prostatic hyperplasia
Con control animals
DHT dihydrotestosterone
DLP dorsolateral prostate
E2F1 E2F transcription factor 1
HMOs Human milk oligosaccharides
Fina rats with BPH orally administrated 5 mg/kg finasteride
PCNA proliferating cell nuclear antigen
PSA prostate-specific antigen
Rb retinoblastoma protein
6SL 0.5 and 6SL 1.0 rats with BPH intraperitoneally administrated 0.5 or 1.0 mg/kg 6SL
TP testosterone propionate
TUMT transurethral microwave thermotherapy
VP ventral prostate
6SL 6′-Sialyllactose
TETP the epithelium tissue from prostate